SARS-CoV-2 Infection, Hospitalization, and Associated Factors Among People Living With HIV in Southeastern China From December 2022 to February 2023: Cross-Sectional Survey.
Wei ChengYun XuHaibo JiangJun LiZhigang HouHaibin MengWei WangChengliang ChaiJianmin JiangPublished in: JMIR public health and surveillance (2024)
After the ease of prevention and control measures in China, we observed a high SARS-CoV-2 infection rate but a low hospitalization rate. General risk factors, such as higher age and vaccination status, and HIV-related parameters, such as the latest CD4 cell count and HIV viral load, were associated with SARS-CoV-2 infection and hospitalization. A booster vaccination campaign for booster doses should be considered among people living with HIV in confronting possible COVID-19 epidemic emergencies in the near future.
Keyphrases
- respiratory syndrome coronavirus
- antiretroviral therapy
- hiv positive
- hiv infected
- hiv testing
- risk factors
- human immunodeficiency virus
- sars cov
- coronavirus disease
- hepatitis c virus
- hiv aids
- men who have sex with men
- single cell
- cell therapy
- south africa
- stem cells
- current status
- mesenchymal stem cells
- peripheral blood
- bone marrow